Mast cells (MCs) evolved as part of the innate immune system more than 500 million years ago to respond to different signals from microorganisms that establish different interactions with the host, ranging from mutualistic to parasitic. This article collection illustrates how MCs influence the immune system's relationship with different microorganisms and how these MC responses modulate subsequent host-microorganism interplay.
In a comprehensive overview, Jiménez et al. describe the MC’s biology and main functions with a particular focus on the up-to-date interaction with microorganisms, ranging from viruses to parasites. They discuss the importance of MC mechanisms to induce protection against infections and they also illustrate the damage associated with exacerbated MC activation during different infectious diseases.
Yu et al. discuss the importance of MC activation during fungal infections. They review experimental evidence of the MC’s role during infection with the fungi Candida albicans, Aspergillus fumigatus, and Sporothrix schenkii.
Because of their strategic location, MCs are sentinels at the epithelial interface and are first responders in host-microbiome interactions. MCs primarily express their interaction through several innate immune receptors, such as Toll-Like Receptors (TLRs). As Soria-Castro, et al. describe during the infection with Listeria monocytogenes, MCs response is mediated through TLR2 activation. However, they can also respond when TLR2 is blocked, using other innate immune receptors.
Draberova et al. describe alternate pathways of MCs activation during infection focusing on Gram-positive bacterial exotoxins that promote cholesterol-dependent cellular lysis. At low concentrations, these exotoxins cause pore formation in the MCs membrane leading to the activation of different cell signaling molecules that induce MC degranulation and production of several inflammatory mediators. Interestingly, other molecules that can modify the MCs membrane integrity can mimic this activation pathway.
However, the significance of MCs in host defense is more evident when we see MCs also modulate the acquired immune system. Palma et al. illustrate how MCs modulate B-cell responses. Their review describes the critical impacts of MCs on B cells using information from both clinical and laboratory studies. They also discuss the implications of these findings on host responses to infections.
Antibody responses can modulate MCs reaction to microorganisms, which is illustrated by Mamontov et al. during influenza virus infection, turning the capacity of MCs to recognize viruses into a damaging response. This study elegantly shows that virus-specific non-neutralizing antibodies can interact with MCs upon infection with the avian influenza virus. It is suggested that this antibody-mediated MC response, which includes significant histamine release, could potentially cause side effects when vaccinated subjects are infected with the influenza virus.
A second level of MC interactions with the adaptive immune response is evident during T cell activation following viral infections. Employing MCs deficient mice, Hackler et al. reveal the critical role played by MCs in promoting adequate dendritic cell activation and the induction of specific T CD8+ responses that limit the infection of lymphocytic choriomeningitis virus.
The ability of MCs to participate in the control of bacterial infections can be exploited by employing distinct polypeptides that target specific molecules on MCs. For example, Amponnawarat et al. show that murepavadin, a lipopolysaccharide transport protein D (LptD)- binding host defense peptidomimetic antimicrobial peptide that targets multi-drug resistant Pseudomona aureginosa, can activate MCs in vitro through Mas-Related G Protein-Coupled Receptor member X2 (MRGPRX2), inducing degranulation and cytokine production. Moreover, in vivo they revealed that murepavadin increases vascular permeability in mice.
Finally, Yeh et al. reveal that the MC’s interactions with microorganisms can be a bidirectional response, where interactions with microbiota impact MC distribution in the lungs. They showed that mice captured in the wild exhibited a remarkable presence of MCs in lung parenchyma compared to specific pathogen-free mice from the conventional laboratory. Remarkably, when laboratory mice were bred in conditions that mimicked the wild environment, they exhibited increased MCs in the lungs.
In conclusion, this research topic updates the current state of knowledge regarding MC crosstalk with mutualistic and parasitic microorganisms and how this interaction impacts innate and adaptive immune response modulating host homeostasis. The MC’s role clearly depends on the nature of its interactions with specific microorganisms, as these interactions can promote either protection or damage to the host. Purposeful modulation of some of these interactions can reveal new therapeutic targets and novel strategies to combat infectious diseases.

